Bayer shares up 1.8% trade after U.S. Roundup rule

Bayer shares up 1.8% trade after U.S. Roundup rule

FRANKFURT, July 16 (Reuters) - Shares in German chemicals company Bayer rose 1.8% in early trade on Tuesday after a U.S. judge slashed a damages awar

A third CRISPR baby may have already been born in China
Elon Musk’s brain-interface company is promising big news. Here’s what it could be.
Greece on GDPR: The high overvalue of health data and how to protect it

FRANKFURT, July 16 (Reuters) – Shares in German chemicals company Bayer rose 1.8% in early trade on Tuesday after a U.S. judge slashed a damages award Bayer owes a California man who blamed its Roundup weed killer for his cancer.

Broker Lang & Schwarz said premarket trades had seen the stock up 4.2%. The stock had fallen 6.5% so far this month.

The judge said evidence against the former Monsanto Co, which Bayer bought last year, supported punitive damages over the glyphosate ingredient contained in Roundup but reduced damages to $20 million from $75 million.

“Next Glyphosate trials will start in August,” he said. “Bayer will only see an ongoing recovery when it enters mediation talks to settle the 13,400 claims.”

Germany’s DAX was 0.06% up.

Source: Reuters


COMMENTS

WORDPRESS: 0
DISQUS: